DexCom Inc (DXCM) - Product Pipeline Analysis, 2017 Update

Date: May 18, 2017
Pages: 31
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D104D1C5CB7EN
Leaflet:

Download PDF Leaflet

DexCom Inc (DXCM) - Product Pipeline Analysis, 2017 Update
Summary

DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom’s in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DexCom Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
DexCom Inc Company Overview
DexCom Inc Company Snapshot
DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
DexCom Inc – Pipeline Analysis Overview
Business Description
DexCom Inc - Key Facts
DexCom Inc - Major Products and Services
DexCom Inc Pipeline Products by Development Stage
DexCom Inc Pipeline Products Overview
DexCom CGM With Accu-Chek Insulin Delivery System
DexCom CGM With Accu-Chek Insulin Delivery System Product Overview
Dexcom G5x
Dexcom G5x Product Overview
First-Gen Verily Sensor
First-Gen Verily Sensor Product Overview
G6 Continuous Glucose Monitor
G6 Continuous Glucose Monitor Product Overview
Second-Gen Verily Sensor
Second-Gen Verily Sensor Product Overview
DexCom Inc - Key Competitors
DexCom Inc - Key Employees
DexCom Inc - Key Employee Biographies
DexCom Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
DexCom Inc, Recent Developments
May 02, 2017: DexCom Reports First Quarter 2017 Financial Results
Mar 24, 2017: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy
Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors
Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results
Feb 16, 2017: Clinical Study Confirms Continuous Glucose Monitoring is as Safe and Effective as Blood Glucose Monitoring
Jan 24, 2017: Dexcom announces publication of key study in the Journal of the American Medical Association demonstrating the value of CGM in reducing A1C and hypoglycemia in diabetes patients on injection therapy
Jan 12, 2017: Centers for Medicare & Medicaid Services Classify Therapeutic Continuous Glucose Monitors as 'Durable Medical Equipment' under Medicare Part B
Jan 11, 2017: The launch of Dexcom Canada will reshape how Canadians living with diabetes access and use continuous glucose monitoring
Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook
Dec 20, 2016: FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
DexCom Inc Pipeline Products by Equipment Type
DexCom Inc Pipeline Products by Indication
DexCom Inc, Key Facts
DexCom Inc, Major Products and Services
DexCom Inc Number of Pipeline Products by Development Stage
DexCom Inc Pipeline Products Summary by Development Stage
DexCom CGM With Accu-Chek Insulin Delivery System - Product Status
DexCom CGM With Accu-Chek Insulin Delivery System - Product Description
Dexcom G5x - Product Status
Dexcom G5x - Product Description
First-Gen Verily Sensor - Product Status
First-Gen Verily Sensor - Product Description
G6 Continuous Glucose Monitor - Product Status
G6 Continuous Glucose Monitor - Product Description
Second-Gen Verily Sensor - Product Status
Second-Gen Verily Sensor - Product Description
DexCom Inc, Key Employees
DexCom Inc, Key Employee Biographies
DexCom Inc, Subsidiaries
Glossary

LIST OF FIGURES

DexCom Inc Pipeline Products by Equipment Type
DexCom Inc Pipeline Products by Development Stage

COMPANIES MENTIONED

TheraSense Inc
Medtronic Plc
MediSense Inc.
LifeScan Inc
Becton Dickinson and Co
Bayer Corp
Abbott Laboratories
Skip to top


Ask Your Question

DexCom Inc (DXCM) - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: